Advertisement

Environmental Management

, Volume 60, Issue 2, pp 314–322 | Cite as

U.S. News Media Coverage of Pharmaceutical Pollution in the Aquatic Environment: A Content Analysis of the Problems and Solutions Presented by Actors

  • Benjamin Blair
  • Daniel Zimny-Schmitt
  • Murray A. Rudd
Article

Abstract

Pharmaceutical pollution in the aquatic environment is an issue of concern that has attracted attention by the news media. Understanding the factors that contribute to media framing of pharmaceutical pollution may lead to a better understanding of the management and governance of this issue, including why these pollutants are generally unregulated at this time. This study conducted a content analysis of 405 newspaper articles (81 had substantive information on the topic) from 2007 to 2014, using the search terms “water” and “pharmaceuticals” in the Chicago Tribune, Denver Post, Los Angeles Times, New York Daily News, New York Times, USA Today, Wall Street Journal, and Washington Post. We sought to analyze the factors that contributed to the news media presentation of pharmaceutical pollution in the United States, including the presentation of the risks/safety and solutions by various actors. We found that the primary issues in the news media were uncertainty regarding public health and harm to the environment. The primary solutions recommended within the news media were implementing additional water treatment technologies, taking unused pharmaceuticals to predetermined sites for disposal (take-back programs), and trash disposal of unused pharmaceuticals. Water utilities and scientists presented improved water treatment technology, government actors presented take-back programs, and pharmaceutical representatives, while sparsely involved in the news media, presented trash disposal as their primary solutions. To advance the understanding of the management of pharmaceutical pollution, this article offers further insight into the debate and potential solutions within the news media presentation of this complex scientific topic.

Keywords

Pharmaceuticals Emerging Contaminants PPCPs News Media 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests.

References

  1. Al Aukidy M, Verlicchi P, Jelic A et al. (2012) Monitoring release of pharmaceutical compounds: occurrence and environmental risk assessment of two WWTP effluents and their receiving bodies in the Po Valley, Italy. Sci Total Environ 438:15–25. doi: 10.1016/j.scitotenv.2012.08.061 CrossRefGoogle Scholar
  2. Bean TG, Bergstrom E, Thomas-Oates J et al. (2016) Evaluation of a novel approach for reducing emissions of pharmaceuticals to the environment. Environ Manage 58:707–720. doi: 10.1007/s00267-016-0728-9 CrossRefGoogle Scholar
  3. Blair B, Kehl J, Klaper R (2015a) Assessing emerging wastewater regulations to minimize the risk from pharmaceuticals and personal care products. Manag Environ Qual Int J 26:966–983. doi: 10.1108/MEQ-12-2014-0171 CrossRefGoogle Scholar
  4. Blair BD (2016) Potential upstream strategies for the mitigation of pharmaceuticals in the aquatic environment: a brief review. Curr Environ Health Rep 3:153–160. doi: 10.1007/s40572-016-0088-x CrossRefGoogle Scholar
  5. Blair BD, Weible CM, Heikkila T, McCormack L (2015b) Certainty and uncertainty in framing the risks and benefits of hydraulic fracturing in the Colorado News Media. Risk, Hazards & Crisis in Public Policy 6:290–307.Google Scholar
  6. Bonner L (2015) Pharma industry must pay for drug take-back programs in some California counties. Pharm Today 21:78. doi: 10.1016/S1042-0991(15)30264-4 Google Scholar
  7. Boxall ABA, Rudd MA, Brooks BW et al. (2012) Pharmaceuticals and personal care products in the environment: what are the big questions? Environ Health Perspect 120:1221–1229. doi: 10.1016/j.envint.2013.06.012 CrossRefGoogle Scholar
  8. Boykoff MT, Boykoff JM (2007) Climate change and journalistic norms: a case-study of US mass-media coverage. Geoforum 38:1190–1204. doi: 10.1016/j.geoforum.2007.01.008 CrossRefGoogle Scholar
  9. Brodin T, Fick J, Jonsson M, Klaminder J (2013) Dilute concentrations of a psychiatric drug alter behavior of fish from natural populations. Science 339:814–815. doi: 10.1126/science.1226850 CrossRefGoogle Scholar
  10. Brooks BW (2014) Fish on Prozac (and Zoloft): ten years later. Aquat Toxicol 151:61–67. doi: 10.1016/j.aquatox.2014.01.007 CrossRefGoogle Scholar
  11. Brooks BW, Chambliss CK, Stanley JK et al. (2005) Determination of select antidepressants in fish from an effluent-dominated stream. Environ Toxicol Chem 24:464–469. doi: 0730-7268/05CrossRefGoogle Scholar
  12. Bull RJ, Crook J, Whittaker M, Cotruvo JA (2011) Therapeutic dose as the point of departure in assessing potential health hazards from drugs in drinking water and recycled municipal wastewater. Regul Toxicol Pharmacol 60:1–19. doi: 10.1016/j.yrtph.2009.12.010 CrossRefGoogle Scholar
  13. Cook SM, Vanduinen BJ, Love NG, Skerlos SJ (2012) Life cycle comparison of environmental emissions from three disposal options for unused pharmaceuticals. Environ Sci Technol 46:5535–5541. doi: 10.1021/es203987b CrossRefGoogle Scholar
  14. Daughton C, Ternes T (1999) Pharmaceuticals and personal care products in the enviornment: agents of subtle change? Environ Health Perspect 107:907–938. doi: 10.1289/ehp.99107s6907 CrossRefGoogle Scholar
  15. Daughton CG (2016) Pharmaceuticals and the environment (PiE): evolution and impact of the published literature revealed by bibliometric analysis. Sci Total Environ 562:391–426. doi: 10.1016/j.scitotenv.2016.03.109 CrossRefGoogle Scholar
  16. Daughton CG (2003) Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. II. Drug disposal, waste reduction, and future directions. Environ Health Perspect 111:775–785. doi: 10.1289/ehp.5948 CrossRefGoogle Scholar
  17. Dean C (2007) Drugs are in the water. Does it matter? New York Times. http://www.nytimes.com/2007/04/03/science/earth/03water.html
  18. Dickenson ERV, Snyder SA, Sedlak DL, Drewes JE (2011) Indicator compounds for assessment of wastewater effluent contributions to flow and water quality. Water Res 45:1199–1212. doi: 10.1016/j.watres.2010.11.012 CrossRefGoogle Scholar
  19. Doerr-MacEwen NA, Haight ME (2006) Expert stakeholders’ views on the management of human pharmaceuticals in the environment. Environ Manage 38:853–866. doi: 10.1007/s00267-005-0306-z CrossRefGoogle Scholar
  20. Donn J, Mendoza M, Pritchard J (2008) An AP investigation: pharmaceuticals found in drinking water. Associated Press. http://hosted.ap.org/specials/interactives/pharmawater_site/day1_01.html
  21. Ferguson PJ, Bernot MJ, Doll JC, Lauer TE (2013) Detection of pharmaceuticals and personal care products (PPCPs) in near-shore habitats of southern Lake Michigan. Sci Total Environ 458–460:187–196. doi: 10.1016/j.scitotenv.2013.04.024 CrossRefGoogle Scholar
  22. Focazio MJ, Kolpin DW, Barnes KK et al. (2008) A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States—(II) untreated drinking water sources. Sci Total Environ 402:201–216. doi: 10.1016/j.scitotenv.2008.02.021 CrossRefGoogle Scholar
  23. Glassmeyer ST, Hinchey EK, Boehme SE et al. (2009) Disposal practices for unwanted residential medications in the United States. Environ Int 35:566–572. doi: 10.1016/j.envint.2008.10.007 CrossRefGoogle Scholar
  24. Guerra P, Kim M, Shah A et al. (2014) Occurrence and fate of antibiotic, analgesic/anti-inflammatory, and antifungal compounds in five wastewater treatment processes. Sci Total Environ 473–474:235–243. doi: 10.1016/j.scitotenv.2013.12.008 CrossRefGoogle Scholar
  25. Heikkila T, Gerlak AK (2005) The formation of large-scale collaborative resource management institutions: clarifying the roles of stakeholders, science, and institutions. Policy Studies Journal 33: 583–612Google Scholar
  26. Jonsson AM (2011) Framing environmental risks in the Baltic Sea: a news media analysis. Ambio 40:121–132. doi: 10.1007/s13280-010-0124-2 CrossRefGoogle Scholar
  27. Kidd KA, Blanchfield PJ, Mills KH et al. (2007) Collapse of a fish population after exposure to a synthetic estrogen. Proc Natl Acad Sci U S A 104:8897–8901. doi: 10.1073/pnas.0609568104 CrossRefGoogle Scholar
  28. Kingdon J (2003) Agendas, alternatives, and public policies. Addison-Wesley Education Publishers Inc. Boston, MAGoogle Scholar
  29. Kolpin DW, Furlong ET, Meyer MT et al. (2002) Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999−2000: a national reconnaissance. Environ Sci Technol 36:1202–1211. doi: 10.1021/es011055j CrossRefGoogle Scholar
  30. Kostich MS, Batt AL, Lazorchak JM (2014) Concentrations of prioritized pharmaceuticals in effluents from 50 large wastewater treatment plants in the US and implications for risk estimation. Environ Pollut 184:354–359. doi: 10.1016/j.envpol.2013.09.013 CrossRefGoogle Scholar
  31. Kumar A, Xagoraraki I (2010) Pharmaceuticals, personal care products and endocrine-disrupting chemicals in U.S. surface and finished drinking waters: a proposed ranking system. Sci Total Environ 408:5972–5989. doi: 10.1016/j.scitotenv.2010.08.048 CrossRefGoogle Scholar
  32. Lapen DR, Topp E, Metcalfe CD et al. (2008) Pharmaceutical and personal care products in tile drainage following land application of municipal biosolids. Sci Total Environ 399:50–65. doi: 10.1016/j.scitotenv.2008.02.025 CrossRefGoogle Scholar
  33. Leung HW, Jin L, Wei S et al. (2013) Pharmaceuticals in tap water: human health risk assessment and proposed monitoring framework in China. Environ Health Perspect 121:839–846. doi: 10.1289/ehp.1206244 CrossRefGoogle Scholar
  34. Liu J-L, Wong M-H (2013) Pharmaceuticals and personal care products (PPCPs): a review on environmental contamination in China. Environ Int 59:208–224. doi: 10.1016/j.envint.2013.06.012 CrossRefGoogle Scholar
  35. Lulofs N (2013) Top 25 U.S. newspapers for March 2013. Alliance for Audited Media. http://auditedmedia.com/news/blog/top-25-us-newspapers-for-march-2013.aspx. Accessed 29 Feb 2016Google Scholar
  36. Masoner JR, Kolpin DW, Furlong ET et al. (2015) Landfill leachate as a mirror of today’s disposable society: pharmaceuticals and other contaminants of emerging concern in final leachate from landfills in the conterminous United States. Environ Toxicol Chem. doi: 10.1002/etc.3219
  37. McNamara PJ, Lapara TM, Novak PJ (2014) The impacts of triclosan on anaerobic community structures, function, and antimicrobial resistance. Environ Sci Technol 48(13):7393–400. doi: 10.1021/es501388v
  38. Meena VD, Dotaniya ML, Saha JK, Patra AK (2015) Antibiotics and antibiotic resistant bacteria in wastewater: impact on environment, soil microbial activity and human health. African Journal of Microbiology Research 9(14):965–978Google Scholar
  39. Metz F, Ingold K (2014) Sustainable wastewater management: is it possible to regulate micropollution in the future by learning from the past? A policy analysis. Sustainability 6:1992–2012. doi: 10.3390/su6041992 CrossRefGoogle Scholar
  40. Molinos-Senante M, Hernández-Sancho F, Sala-Garrido R (2010) Economic feasibility study for wastewater treatment: a cost-benefit analysis. Sci Total Environ 408:4396–4402. doi: 10.1016/j.scitotenv.2010.07.014 CrossRefGoogle Scholar
  41. Niemuth NJ, Klaper RD (2015) Emerging wastewater contaminant metformin causes intersex and reduced fecundity in fish. Chemosphere 135:38–45. doi: 10.1016/j.chemosphere.2015.03.060 CrossRefGoogle Scholar
  42. Ort C, Lawrence MG, Reungoat J et al. (2010) Determining the fraction of pharmaceutical residues in wastewater originating from a hospital. Water Res 44:605–615. doi: 10.1016/j.watres.2009.08.002 CrossRefGoogle Scholar
  43. Oulton RL, Kohn T, Cwiertny DM (2010) Pharmaceuticals and personal care products in effluent matrices: a survey of transformation and removal during wastewater treatment and implications for wastewater management. J Environ Monit 12:1956–1978. doi: 10.1039/c0em00068j CrossRefGoogle Scholar
  44. Phillips PJ, Smith SG, Kolpin DW et al. (2010) Pharmaceutical formulation facilities as sources of opioids and other pharmaceuticals to wastewater treatment plant effluents. Environ Sci Technol 44:4910–4916. doi: 10.1021/es100356f CrossRefGoogle Scholar
  45. Ragain L (2009) Risk communication and media coverage of emerging contaminants. Am Water Work Assoc 101:100–105Google Scholar
  46. Riffe D, Lacy S, Fico F (2005) Analyzing media messages: using quantitative content analysis in research, 2nd edn. Routledge, Mahwah, NJGoogle Scholar
  47. Rudd MA (2015) Scientists’ framing of the ocean science-policy interface. Glob Environ Chang 33:44–60. doi: 10.1016/j.gloenvcha.2015.04.006 CrossRefGoogle Scholar
  48. Rudd MA, Ankley GT, Boxall ABA, Brooks BW (2014) International scientists’ priorities for research on pharmaceutical and personal care products in the environment. Integr Environ Assess Manag 10:576–587. doi: 10.1002/ieam.1551 CrossRefGoogle Scholar
  49. Ruhoy IS, Daughton CG (2008) Beyond the medicine cabinet: an analysis of where and why medications accumulate. Environ Int 34:1157–1169. doi: 10.1016/j.envint.2008.05.002 CrossRefGoogle Scholar
  50. Schimmelpfennig S, Kirillin G, Engelhardt C et al. (2012) Seeking a compromise between pharmaceutical pollution and phosphorus load: management strategies for Lake Tegel, Berlin. Water Res 46:4153–4163. doi: 10.1016/j.watres.2012.05.024 CrossRefGoogle Scholar
  51. Sharma VK, Johnson N, Cizmas L et al. (2016) A review of the influence of treatment strategies on antibiotic resistant bacteria and antibiotic resistance genes. Chemosphere 150:702–714. doi: 10.1016/j.chemosphere.2015.12.084 CrossRefGoogle Scholar
  52. Snyder SA (2008) Occurrence, treatment, and toxicological relevance of EDCs and pharmaceuticals in water. Ozone Sci Eng 30:65–69. doi: 10.1080/01919510701799278 CrossRefGoogle Scholar
  53. Sorell TL (2016) Approaches to the development of human health toxicity values for active pharmaceutical ingredients in the environment. AAPS J 18:92–101. doi: 10.1208/s12248-015-9818-5 CrossRefGoogle Scholar
  54. Stark M (2010) Programs aim to safely dispose of old drugs; potentially dangerous medications are being collected by more states. Washington Post, p A02Google Scholar
  55. Stern PC, Dietz T, Kalof L (1993) Value orientations, gender, and environmental concern. Environ Behav 25:322–348CrossRefGoogle Scholar
  56. Stoddard KI, Hodge V, Maxey G et al. (2017) Investigating research gaps of pharmaceutical take back events: an analysis of take back program participants’ socioeconomic, demographic, and geographic characteristics and the public health benefits of take back programs. Environ Manage 0–1. doi: 10.1007/s00267-017-0834-3
  57. Stoutenborough JW, Fette RN, Vedlitz A, Goldsmith CL (2015) Understanding the communication of climate change risk: climate scientists’ perspectives of media sources and policy makers. Risk, Hazards & Crisis in Public Policy 5:365–384Google Scholar
  58. Tang C, Rundblad G (2015) When safe means “dangerous”: a corpus investigation of risk communication in the media. Applied Linguistics 1–23. doi: 10.1093/applin/amv058
  59. Titz A, Döll P (2009) Actor modelling and its contribution to the development of integrative strategies for management of pharmaceuticals in drinking water. Soc Sci Med 68:672–681. doi: 10.1016/j.socscimed.2008.11.031 CrossRefGoogle Scholar
  60. Tong AYC, Peake BM, Braund R (2011) Disposal practices for unused medications in New Zealand community pharmacies. J Prim Health Care 3:197–203. doi: 10.1016/j.envint.2010.10.002 Google Scholar
  61. USEPA (2016) Drinking water contaminant candidate list (CCL) and regulatory determination. https://www.epa.gov/ccl
  62. USFDA (2015) Safe disposal of medicines—disposal of unused medicines: what you should know. http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/EnsuringSafeUseofMedicine/SafeDisposalofMedicines/ucm186187.htm. Accessed 9 Jan 2016Google Scholar
  63. USFDA (2017) Disposal of unused medicines: what you should know. https://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/EnsuringSafeUseofMedicine/SafeDisposalofMedicines/ucm186187.htm#MEDICINES. Accessed 1 Jan 2017Google Scholar
  64. Viera AJ, Garrett JM (2005) Understanding interobserver agreement: The kappa statistic. Fam Med 37(5):360–363.Google Scholar
  65. Wang X, Boxall A, Howley P, Rudd M (2015) Priority research questions on the environmental impacts of pharmaceutical and personal care products in China: insights from Chinese scientists. Chinese J Urban Environ Stud 3:1550022. doi: 10.1142/S2345748115500220 CrossRefGoogle Scholar
  66. Wei J, Wei Y, Western A et al. (2015) Evolution of newspaper coverage of water issues in Australia during 1843–2011. Ambio 44:319–331. doi: 10.1007/s13280-014-0571-2
  67. Zhong W, Maradit-Kremers H, St. Sauver JL et al. (2013) Age and sex patterns of drug prescribing in a defined American population. Mayo Clin Proc 88:697–707. doi: 10.1016/j.mayocp.2013.04.021 CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  1. 1.Department of Environmental and Occupational Health, Colorado School of Public HealthUniversity of Colorado DenverDenverUSA
  2. 2.Department of Geography and the EnvironmentUniversity of DenverDenverUSA
  3. 3.Department of Environmental SciencesEmory UniversityAtlantaUSA

Personalised recommendations